# OnCo record paper-cd19-multiple-myeloma-lancet-haematol-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-cd19-multiple-myeloma-lancet-haematol-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-cd19-multiple-myeloma-lancet-haematol-2019" ;
  schema:name "A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial"@en ;
  schema:description "Phase 2 or 3 results paper on CD19 in Multiple myeloma, in The Lancet Haematology (2019), one of the most cited Europe PMC records with CD19 in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-cd19-multiple-myeloma-lancet-haematol-2019/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s2352-3026(19)30115-2>, <https://pubmed.ncbi.nlm.nih.gov/31378662/>, <https://europepmc.org/article/MED/31378662> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s2352-3026(19)30115-2> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Yan Z, Cao J, Cheng H, et al." ;
  onco:journals <https://onco.cc/journals/lancet-haematology/> .